United Therapeutics Corporation – Transparency in Payments

The US Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a component of the Affordable Care Act. The Act requires health care manufacturers, including United Therapeutics, to track financial transactions with certain health care providers (HCPs) and health care organizations (HCOs) and to disclose those transactions on an annual basis. We support the Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence. If you have questions on the data contained in the reports, please email us at: OpenPayments@unither.com

Information exchanged with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and patient organizations leads to newer and better therapies and, most importantly, enhanced care for patients. We believe interactions with healthcare professionals and healthcare organizations are essential to advance patient care, gain insights into unmet medical needs and progress the development of medicines. Our interactions with HCPs and HCOs are based on trust, transparency and integrity, with a goal of providing the public with greater visibility into these interactions to ensure public trust and confidence. United Therapeutics engages in a range of activities from clinical research to sponsorships to educational activities to exchange information on how medicines fit into the patient pathway. By bringing greater transparency to these relationships, United Therapeutics demonstrates its ongoing commitment to strengthening the basis for future collaboration.

United Therapeutics is committed to making a remarkable impact on patients’ lives and their caregivers. We combine advanced science with a deep knowledge of the patient experience and healthcare systems to help people live better, more productive lives. We pursue learning about patient experiences to understand the issues, concerns and priorities of people affected by disease.

Patient organizations are a source of valuable information and support for patients and their caregivers. We foster patient organization relationships based on mutual trust, respect and goals that reflect United Therapeutics’ transparent and ethical behavioral standards. Through these relationships, United Therapeutics contributes to informing patients and caregivers about disease states, treatment options and how to improve quality of life. These partnerships facilitate dialogue between interested parties and help create new, cost-effective health care delivery models. Annually, United Therapeutics publishes the financial support provided to European Patient Organizations. Our publication of the following country reports demonstrates our commitment to transparent disclosure of our financial relationships with patient organizations.